Samchundang Pharmaceutical "Suspends Negotiations on 300 Billion KRW Investment with Global Pharma for Vaccine Development"
[Asia Economy Reporter Minji Lee] Samchundang Pharmaceutical announced on the 2nd that it had been in talks with a global pharmaceutical company in May last year to invest 300 billion KRW in developing the world's best oral COVID-19 vaccine. However, considering the demand and growth potential of the COVID vaccine market, the overseas partner informed them that continued development would be difficult, leading to the decision to halt the negotiations.
Hot Picks Today
"Do We Need to Panic Buy Again?" War Drives 30% Price Surge... Even the Bedroom Feels the Impact
- [Breaking] Lee Jae-yong: "All Samsung members are united as one... We must pool our wisdom and move in a single direction"
- "Is a 10,000 KOSPI Breakthrough Possible?" Target Index Raised by 40%... Securities Firms Release Outlook [Weekend Money]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- "Student ID Rentals Reach 500,000 Won... Black Market and Line-holding Services Surge"
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![[Breaking] Lee Jae-yong: "All Samsung members are united as one... We must pool our wisdom and move in a single direction"](https://cwcontent.asiae.co.kr/asiaresize/307/2026010108513575608_1767225095.png)